Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,1607 USD | +0,44% | -0,80% | -89,36% |
21/03 | CALIDI BIOTHERAPEUTICS, INC. : HC Wainwright herhaalt koopadvies | ZM |
07/02 | Sectorupdate: Gezondheidszorgaandelen hoger aan het eind van de middag | MT |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 8,15 mln. 7,63 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -40 mln. -37,41 mln. | Nettowinst (verlies) 2025 * | -42 mln. -39,28 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,16
x | K/w-verhouding 2025 * |
-0,26
x | Werknemers | 41 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 55,48% |
1 dag | +0,44% | ||
1 week | -0,80% | ||
Lopende maand | -71,56% | ||
1 maand | -71,81% | ||
3 maanden | -83,43% | ||
6 maanden | -93,57% | ||
Lopend jaar | -89,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Allan Camaisa
CEO | Chief Executive Officer | - | - |
Andrew Jackson
DFI | Director of Finance/CFO | 55 | 30-10-23 |
Amish A. Patel
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Ng
BRD | Director/Board Member | 49 | - |
Alan Stewart
BRD | Director/Board Member | 60 | 10-10-23 |
James Schoeneck
BRD | Director/Board Member | 66 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 0,1607 | +0,44% | 886 544 |
25-04-24 | 0,16 | +1,33% | 549 010 |
24-04-24 | 0,1579 | -5,45% | 981 418 |
23-04-24 | 0,167 | +7,05% | 2 055 971 |
22-04-24 | 0,156 | -3,70% | 735 801 |
uitgestelde koers Nyse, 26 april 2024 om 22:10 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-89,36% | 8,15 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |